Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Van Cutsem

Showing results (1-10 of 249) with videos related to

Pageof 25
Sort By:
Anti-Cancer Drugs|August 1, 1997
Future developments with 'Tomudex' (raltitrexed)E Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectivesE Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
A glimpse of the future. new directions in the treatment of colorectal cancerE Van Cutsem
Acta Gastro-Enterologica Belgica|January 1, 1993
Georges Brohee Prize. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformationsE Van Cutsem
Expert Opinion on Investigational Drugs|July 5, 2005
Raltitrexed (Tomudex)E Van Cutsem
Gastrointestinal Endoscopy Clinics of North America|October 1, 1996
Pharmacologic therapy of arteriovenous malformationsE Van Cutsem, H Piessevaux
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-upE Van Cutsem, J Oliveira,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsS Segaert, E Van Cutsem
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-upE Van Cutsem, J Oliveira,
Bulletin Du Cancer|February 5, 1999
[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]E Van Cutsem, M Peeters
Pageof 25

Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
Anti-Cancer Drugs|August 1, 1997
Future developments with 'Tomudex' (raltitrexed)E Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectivesE Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
A glimpse of the future. new directions in the treatment of colorectal cancerE Van Cutsem
Acta Gastro-Enterologica Belgica|January 1, 1993
Georges Brohee Prize. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformationsE Van Cutsem
Expert Opinion on Investigational Drugs|July 5, 2005
Raltitrexed (Tomudex)E Van Cutsem
Gastrointestinal Endoscopy Clinics of North America|October 1, 1996
Pharmacologic therapy of arteriovenous malformationsE Van Cutsem, H Piessevaux
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-upE Van Cutsem, J Oliveira,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsS Segaert, E Van Cutsem
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-upE Van Cutsem, J Oliveira,
Bulletin Du Cancer|February 5, 1999
[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]E Van Cutsem, M Peeters
Pageof 25